Aptinyx Insiders

APTXDelisted Stock  USD 0.07  0.01  16.67%   
Aptinyx employs about 12 people. The company is managed by 20 executives with a total tenure of roughly 89 years, averaging almost 4.0 years of service per executive, having 0.6 employees per reported executive. Break down of Aptinyx's management performance can provide insight into the company performance.
Norbert Riedel  CEO
President CEO, Director
Wilbur Gantz  Chairman
Independent Chairman of the Board
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Aptinyx Management Team Effectiveness

The company has return on total asset (ROA) of (0.5135) % which means that it has lost $0.5135 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3806) %, meaning that it created substantial loss on money invested by shareholders. Aptinyx's management efficiency ratios could be used to measure how well Aptinyx manages its routine affairs as well as how well it operates its assets and liabilities.

Aptinyx Workforce Comparison

Aptinyx is rated below average in number of employees category among related companies. The total workforce of Health Care industry is presently estimated at about 826. Aptinyx claims roughly 12.0 in number of employees contributing just under 2% to equities under Health Care industry.

Aptinyx Notable Stakeholders

An Aptinyx stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Aptinyx often face trade-offs trying to please all of them. Aptinyx's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Aptinyx's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Norbert RiedelPresident CEO, DirectorProfile
Wilbur GantzIndependent Chairman of the BoardProfile
Patricia AdamsVice President - Human Resources and AdministrationProfile
Elisha GouldIndependent DirectorProfile
Robert HombachIndependent DirectorProfile
Henry GosebruchIndependent DirectorProfile
Patrick EnrightIndependent DirectorProfile
James TopperIndependent DirectorProfile
Adam KoppelIndependent DirectorProfile
Kathryn KingVP OperationsProfile
Torsten MadsenChief Medical OfficerProfile
David HouckChief Development OfficerProfile
Patrick FlavinSr RelationsProfile
Ashish KhannaChief Business OfficerProfile
Harald MDVP AffairsProfile
MD BChPres CEOProfile
Joseph MoskalChief Scientific OfficerProfile
Molly DirVP HRProfile
Tim NoffkeVP StaffProfile
Andrew KiddChief Commercial OfficerProfile

About Aptinyx Management Performance

The success or failure of an entity such as Aptinyx often depends on how effective the management is. Aptinyx management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Aptinyx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Aptinyx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois. Aptinyx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.
The data published in Aptinyx's official financial statements usually reflect Aptinyx's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Aptinyx. For example, before you start analyzing numbers published by Aptinyx accountants, it's critical to develop an understanding of what Aptinyx's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Aptinyx's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aptinyx's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Aptinyx's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Aptinyx. Please utilize our Beneish M Score to check the likelihood of Aptinyx's management manipulating its earnings.

Aptinyx Workforce Analysis

Traditionally, organizations such as Aptinyx use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Aptinyx within its industry.

Aptinyx Manpower Efficiency

Return on Aptinyx Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee5.4M
Net Loss Per Executive3.2M
Working Capital Per Employee4.8M
Working Capital Per Executive2.9M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Consideration for investing in Aptinyx Stock

If you are still planning to invest in Aptinyx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptinyx's history and understand the potential risks before investing.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Directory
Find actively traded commodities issued by global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios